The development of generic versions of innovator medicines is a global public health need.
Pharmaceutical continuous manufacturing: How USP standards and related programs support quality, innovation & supply chain resilience
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis
Many of the drug ingredients used in generic medicines around the world are produced in China, an